PP
GHDX

PDT Partners’s Genomic Health, Inc. GHDX Stock Holding History

PDT Partners’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-59,500
Closed -$3.46M – 511
2019
Q2 		$3.46M Buy
59,500
+29,350
+97% +$1.74M 0.2% 137
2019
Q1 		$2.11M Sell
30,150
-16,550
-35% -$1.23M 0.12% 192
2018
Q4 		$3.01M Buy
46,700
+14,400
+45% +$1.01M 0.17% 158
2018
Q3 		$2.27M Buy
+32,300
New +$1.89M 0.09% 228
2018
Q1 		– Sell
-14,127
Closed -$483K – 633
2017
Q4 		$483K Sell
14,127
-2,636
-16% -$84K 0.01% 430
2017
Q3 		$538K Sell
16,763
-2,600
-13% -$82K 0.02% 423
2017
Q2 		$630K Sell
19,363
-6,400
-25% -$203K 0.03% 382
2017
Q1 		$811K Sell
25,763
-4,382
-15% -$130K 0.04% 338
2016
Q4 		$886K Buy
30,145
+182
+0.6% +$5.55K 0.06% 345
2016
Q3 		$867K Hold
29,963
– – 0.05% 322
2016
Q2 		$776K Hold
29,963
– – 0.06% 285
2016
Q1 		$742K Hold
29,963
– – 0.05% 343
2015
Q4 		$1.05M Sell
29,963
-45,166
-60% -$1.21M 0.14% 204
2015
Q3 		$1.59M Sell
75,129
-53,598
-42% -$1.38M 0.04% 549
2015
Q2 		$3.58M Buy
128,727
+45,185
+54% +$1.27M 0.09% 274
2015
Q1 		$2.55M Buy
83,542
+6,000
+8% +$191K 0.06% 380
2014
Q4 		$2.48M Buy
77,542
+4,700
+6% +$153K 0.24% 92
2014
Q3 		$2.06M Hold
72,842
– – 0.05% 409
2014
Q2 		$2M Buy
72,842
+1,500
+2% +$39.9K 0.05% 438
2014
Q1 		$1.88M Hold
71,342
– – 0.05% 473
2013
Q4 		$2.09M Sell
71,342
-8,378
-11% -$266K 0.25% 80
2013
Q3 		$2.44M Sell
79,720
-28,282
-26% -$946K 0.07% 409
2013
Q2 		$3.42M Buy
+108,002
New +$3.55M 0.08% 305

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

PDT Partners's GHDX Position: Q3 2019 in Review

PDT Partners sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 59,500 shares — an estimated $3.46M sold.

PDT Partners first reported a position in GHDX in Q2 2013 and held it in 23 quarters. The position peaked at $3.58M in Q2 2015. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • PDT Partners reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • PDT Partners sold 59,500 Genomic Health, Inc. shares in Q3 2019, an estimated $3.46M.
  • PDT Partners first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 23 quarters.
  • PDT Partners's Genomic Health, Inc. position peaked at $3.58M in Q2 2015.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on PDT Partners's 13F filing for Q3 2019, filed 14 Nov 2019.